Reducing Drug Prices for Seniors Act.

Hozzl · 2025-08-09T03:38:24Z

Explore the details of Senate Bill 2617 Reducing Drug Prices for Seniors Act. currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

8/9/2025, 3:38 AM

Summary of Bill S 2617

The bill "A bill to amend title XVIII of the Social Security Act to require that coinsurance for drugs under Medicare part D be based on the drug's net price and not the drug's list price," designated as S. 2617 in the 119th Congress and introduced on July 31, 2025, aims to change how coinsurance for drugs in Medicare part D is calculated, shifting the basis from the drug's list price to its net price.

Congressional Summary of S 2617

Reducing Drug Prices for Seniors Act

This bill requires the coinsurance amount for covered drugs under the Medicare prescription drug benefit to be based on the net price of the drug (i.e., the negotiated price under the prescription drug plan net of any manufacturer price concessions), rather than the list price of the drug, if the net price is lower.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2617

Bill S 2617 is currently in the status of Bill Introduced since July 31, 2025. Bill S 2617 was introduced during Congress 119 and was introduced to the Senate on July 31, 2025. Bill S 2617's most recent activity was Read twice and referred to the Committee on Finance. as of July 31, 2025

Bipartisan Support of Bill S 2617

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2617

Primary Policy Focus

Alternate Title(s) of Bill S 2617

A bill to amend title XVIII of the Social Security Act to require that coinsurance for drugs under Medicare part D be based on the drug's net price and not the drug's list price.